The aim of this study was to investigate the impact of SUVmax fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) measured in the primary tumor, pelvic and para-aortic node with disease-free survival (DFS) and overall survival (OS) in patients with locally advanced cervical cancer.
Cima, S., Perrone, A.M., Castellucci, P., Macchia, G., Buwenge, M., Cammelli, S., et al. (2018). Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 28(3), 575-580 [10.1097/IGC.0000000000001207].
Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer
Cima, Simona;Perrone, Anna Myriam;Castellucci, Paolo;Buwenge, Milly;Cammelli, Silvia;FERIOLI, MARTINA;Galuppi, Andrea;Salizzoni, Eugenio;Rubino, Daniela;Fanti, Stefano;De Iaco, Pierandrea;Morganti, Alessio Giuseppe
2018
Abstract
The aim of this study was to investigate the impact of SUVmax fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) measured in the primary tumor, pelvic and para-aortic node with disease-free survival (DFS) and overall survival (OS) in patients with locally advanced cervical cancer.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
